- Home
- CRMD
CRMD
CorMedix Inc.
as 04-22-2025 4:00pm EST
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | BERKELEY HEIGHTS |
| Market Cap: | 464.7M | IPO Year: | 2010 |
| Target Price: | $14.50 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.61 - $13.85 | Next Earning Date: | 05-08-2025 |
| Revenue: | $43,472,170 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 207.65% | Revenue Growth (next year): | 50.13% |
Latest CorMedix Inc. News
CRMD Breaking Stock News: Dive into CRMD Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years
TipRanks
13 days ago
RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term
GlobeNewswire
15 days ago
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
GlobeNewswire
20 days ago
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
Simply Wall St.
a month ago
Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value
GuruFocus.com
a month ago
Cormedix Inc (CRMD) Q4 2024 Earnings Call Highlights: A Profitable Quarter Amidst Strategic ...
GlobeNewswire
a month ago
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GuruFocus.com
a month ago
Cormedix Inc (CRMD) Q4 2024: Everything You Need To Know Ahead Of Earnings
Compare CRMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRMD CorMedix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.